The Medicare Choices Care Model: Either/Or Becomes This and That

“I see it all perfectly; there are two possible situations – one can either do this or that.”

You would be forgiven if you thought this quote was about a Medicare policy concerning whether a patient could either continue with curative treatment or enter into hospice care. You would be forgiven, but you would still be wrong – and wrong twice.

First, the quote is not from Medicare, but from the great 19th-century Danish thinker Soren Kierkegaard’s appropriately titled book, “Either/Or.”

Second and most importantly, under the new Medicare Choices Care Model (MCCM) trial program, terminally ill Medicare patients will no longer have to choose either curative therapy or hospice care. In 2014, the Centers for Medicare & Medicaid Services (CMS) determined that only 44 percent of terminal Medicare beneficiaries used their hospice benefit during the final stages of their illnesses, and that those who used it did so for only a very short time. Medicare developed the MCCM to remedy this.

The goal of the MCCM program is to increase the number of terminally ill patients entering into hospice care by waiving the requirement that patients must forgo treatments such as chemotherapy. A Phase 1 pilot program of the MCCM was launched in January 2016 and involved 30 hospices in multiple states.

Due to the robust interest in the Phase 1 pilot, a second phase is planned to debut on Jan. 1, 2018, increasing the number of hospice providers to 140. Medicare anticipates that the 2018 Phase 2 rollout will enroll 150,000 terminally ill patients limited to four diagnostic groups: HIV/AIDS, chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), and cancer. The MCCM trial program is planned to run until Dec. 31, 2020.

The intent of this MCCM trial program is to determine if expanded benefits involving both continuing curative treatment and hospice care will increase earlier enrollment of Medicare patients in hospice – and to see if this will improve care, enhance satisfaction, and reduce costs.

Medical thought leaders have long been persuaded that allowing concomitant curative therapies and hospice care will improve quality of life for patients and caregivers, but will not increase costs. The expectation is that by offering the choice of hospice care without eliminating continuing curative therapies, enrollment in hospice will increase as more Medicare beneficiaries avail themselves of palliative care for themselves and of respite care for their families.

The very positive response to Phase 1 of the MCCM highlights the very difficult choices patients and their families have had to make in the past about whether to either continue with curative treatment or forsake this treatment for palliation and comfort. In addition to the four diagnostic categories to be eligible for the MCCM, patients must not have elected the Medicare or Medicaid hospice benefit in the previous 30 days.

The nuts and bolts of MCCM will work something like this for patients and their doctors – under MCCM, the notice of election of hospice will not turn off Part A, B, or D coverage, so services to treat the terminal condition can continue and be billed as a separate claim. These Part A, B, and D services for which providers can continue to bill Medicare include the following:

  • Physical therapy
  • Occupational therapy
  • Speech therapy
  • Drugs for management of pain
  • Drugs for management of symptoms of the terminal illness
  • Medical equipment and supplies
  • Physical services
  • Short-term inpatient care for pain and symptom management

Payment to hospice differs from traditional payment. Hospices participating in MCCM will not receive the Medicare hospice benefit per diem rate. Instead the MCCM will pay hospices a flat fee of $400 monthly for 15 or more days of services, per month. If services are provided for fewer than 15 days per month, the monthly payment decreases to $200. Among the MCCM hospice services covered under the per-month payment, and not subject to a copay, are the following:

  • Counseling services
  • Psycho-social assessment
  • Nursing services
  • Medical social services
  • Hospice aide and homemakers services
  • In-home respite care

Medicare’s expectation is that patients will enter the MCCM through both physician and hospice referral. CMS published a recent MLN Matters in May 2017 detailing the MCCM, which can be accessed online at https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNMattersArticles/Downloads/MM10094.pdf.

The MCCM is an innovative CMS program designed to serve Medicare’s most vulnerable population – the terminally ill. It is Medicare’s intent that those patients whose clinical trajectory is headed toward death will no longer have to choose between either the hope of curative therapy and or the comfort of hospice care.

Under the MCCM, “either or” really will become “this and that.”

Facebook
Twitter
LinkedIn

Related Stories

Transparency in Coverage Final Rule

Transparency in Coverage Final Rule

The healthcare industry’s landscape shifted dramatically with the implementation of the Transparency in Coverage (TiC) Final Rule. For compliance professionals navigating this regulatory terrain, understanding

Read More

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

2026 IPPS Masterclass 3: Master MS-DRG Shifts and NTAPs

2026 IPPS Masterclass Day 3: MS-DRG Shifts and NTAPs

This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 14, 2025
2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

This second session in our 2026 IPPS Masterclass will feature a review the FY26 changes to ICD-10-PCS codes. This information will be presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 13, 2025
2026 IPPS Masterclass 1: Master ICD-10-CM Changes

2026 IPPS Masterclass Day 1: Master ICD-10-CM Changes

This first session in our 2026 IPPS Masterclass will feature an in-depth explanation of FY26 changes to ICD-10-CM codes and guidelines, CCs/MCCs, and revisions to the MCE, presented by presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 12, 2025

Trending News

Featured Webcasts

The Two-Midnight Rule: New Challenges, Proven Strategies

The Two-Midnight Rule: New Challenges, Proven Strategies

RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.

June 19, 2025
Open Door Forum Webcast Series

Open Door Forum Webcast Series

Bring your questions and join the conversation during this open forum series, live every Wednesday at 10 a.m. EST from June 11–July 30. Hosted by Chuck Buck, these fast-paced 30-minute sessions connect you directly with top healthcare experts tackling today’s most urgent compliance and policy issues.

June 11, 2025
Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Substance abuse is everywhere. It’s a complicated diagnosis with wide-ranging implications well beyond acute care. The face of addiction continues to change so it’s important to remember not just the addict but the spectrum of extended victims and the other social determinants and legal ramifications. Join John K. Hall, MD, JD, MBA, FCLM, FRCPC, for a critical Q&A on navigating substance abuse in 2025.  Register today and be a part of the conversation!

July 16, 2025

Trending News

Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24